Using a cutoff value of 40.720ng/ml, the L1CAM has sensitivities of 83.1%, 66.1%, 76.6% and 69.2%, has specificities of 62.2%, 62.2%, 62.2% and 62.2% in the GC, EJA, early-stage GC and early-stage EJA patients, respectively (Table 3). This evidence concerns the gene L1CAM and gastric cancer.